PBI
66
-6
SPG
46
-18
RIG
37
-9
XOM
48
-17
UNP
39
-19
KEY
74
2
FIS
55
-15
DTE
36
2
TDC
63
-15
HD
34
3
NOC
51
-3
MSI
43
6
VIX
46
13
MPC
39
-2
PEP
38
-18
WEC
43
-27
RHI
40
-12
TJX
65
-4
UPS
40
-18
SNA
49
-20
PBI
66
-6
SPG
46
-18
RIG
37
-9
XOM
48
-17
UNP
39
-19
KEY
74
2
FIS
55
-15
DTE
36
2
TDC
63
-15
HD
34
3
NOC
51
-3
MSI
43
6
VIX
46
13
MPC
39
-2
PEP
38
-18
WEC
43
-27
RHI
40
-12
TJX
65
-4
UPS
40
-18
SNA
49
-20
Financhill
Back

Vanguard Intermediate-Term Corp Bond Idx Fund ETF Vs. Rhythm Pharmaceuticals, Inc. Industry Stock Comparison

Sell
45

VCIT
Vanguard Intermediate-Term Corp Bond Idx Fund ETF

Last Price:
$83.76
Seasonality Move:
-0.39%
Sell
50

RYTM
Rhythm Pharmaceuticals, Inc.

Last Price:
$111.57
Seasonality Move:
-13.08%
Sell
45
Vanguard Intermediate-Term Corp Bond Idx Fund ETF (VCIT) is a Sell

Is Vanguard Intermediate-Term Corp Bond Idx Fund ETF a Buy, Sell or Hold?

  • The current Vanguard Intermediate-Term Corp Bond Idx Fund ETF [VCIT] share price is $83.88. The Score for VCIT is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • VCIT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
50
Rhythm Pharmaceuticals, Inc. (RYTM) is a Sell

Is Rhythm Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current Rhythm Pharmaceuticals, Inc. [RYTM] share price is $111.86. The Score for RYTM is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • RYTM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

VCIT Stock Price Chart

What is Vanguard Intermediate-Term Corp Bond Idx Fund ETF's stock price today?

  • The Vanguard Intermediate-Term Corp Bond Idx Fund ETF share price today is $83.88
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VCIT is experiencing slight buying pressure.

RYTM Stock Price Chart

What is Rhythm Pharmaceuticals, Inc.'s stock price today?

  • The Rhythm Pharmaceuticals, Inc. share price today is $111.86
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing slight selling pressure.

VCIT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 6.69 Buy
Relative Strength Index (14 RSI): 47.96 Sell
Chaikin Money Flow: 2074078 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (83.66 - 84.22) Sell
Bollinger Bands (100): (83.27 - 84.37) Buy

RYTM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 8.92 Buy
Relative Strength Index (14 RSI): 57.01 Buy
Chaikin Money Flow: -264527 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (99.99 - 110.55) Buy
Bollinger Bands (100): (94.91 - 108.39) Buy

VCIT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 83.85 Buy
20-day SMA: 84.01 Sell
50-day SMA: 84.07 Sell
200-day SMA: 82.65 Buy
8-day EMA: 18.64 Buy
20-day EMA: 7.99 Buy
50-day EMA: 3.29 Buy
200-day EMA: 0.83 Buy

RYTM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 109.83 Buy
20-day SMA: 106.87 Buy
50-day SMA: 105.94 Buy
200-day SMA: 82.62 Buy
8-day EMA: 24.86 Buy
20-day EMA: 10.65 Buy
50-day EMA: 4.39 Buy
200-day EMA: 1.11 Buy

Vanguard Intermediate-Term Corp Bond Idx Fund ETF Earnings Growth & VCIT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Rhythm Pharmaceuticals, Inc. Earnings Growth & RYTM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.99 per share, and an increase next year of $0.47 per share.

Vanguard Intermediate-Term Corp Bond Idx Fund ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Rhythm Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):